Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An integrative translational approach to study heart failure with preserved ejection fraction: a position paper from the Working Group on Myocardial Function of the European Society of Cardiology
André P. Lourenço, Adelino Leite‐Moreira, Jean‐Luc Balligand, et al.
European Journal of Heart Failure (2017) Vol. 20, Iss. 2, pp. 216-227
Open Access | Times Cited: 94

Showing 1-25 of 94 citing articles:

Epidemiology of heart failure
Amy Groenewegen, Frans H. Rutten, Arend Mosterd, et al.
European Journal of Heart Failure (2020) Vol. 22, Iss. 8, pp. 1342-1356
Open Access | Times Cited: 1458
How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
Burkert Pieske, Carsten Tschöpe, Rudolf A. de Boer, et al.
European Heart Journal (2019) Vol. 40, Iss. 40, pp. 3297-3317
Open Access | Times Cited: 1322
Research Priorities for Heart Failure With Preserved Ejection Fraction
Sanjiv J. Shah, Barry A. Borlaug, Dalane W. Kitzman, et al.
Circulation (2020) Vol. 141, Iss. 12, pp. 1001-1026
Open Access | Times Cited: 326
How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
Burkert Pieske, Carsten Tschöpe, Rudolf A. de Boer, et al.
European Journal of Heart Failure (2020) Vol. 22, Iss. 3, pp. 391-412
Open Access | Times Cited: 302
Metabolic inflammation in heart failure with preserved ejection fraction
Gabriele G. Schiattarella, Daniele Rodolico, Joseph A. Hill
Cardiovascular Research (2020) Vol. 117, Iss. 2, pp. 423-434
Open Access | Times Cited: 170
The effects of liraglutide and dapagliflozin on cardiac function and structure in a multi-hit mouse model of heart failure with preserved ejection fraction
Coenraad Withaar, Laura M G Meems, George Markousis‐Mavrogenis, et al.
Cardiovascular Research (2020) Vol. 117, Iss. 9, pp. 2108-2124
Open Access | Times Cited: 159
Nicotinamide for the treatment of heart failure with preserved ejection fraction
Mahmoud Abdellatif, Viktoria Trummer-Herbst, Franziska Koser, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 580
Open Access | Times Cited: 146
Therapeutic potential of targeting oxidative stress in diabetic cardiomyopathy
Nikole J. Byrne, Namakkal S. Rajasekaran, E. Dale Abel, et al.
Free Radical Biology and Medicine (2021) Vol. 169, pp. 317-342
Open Access | Times Cited: 125
Heart Failure With Preserved Ejection Fraction: Heterogeneous Syndrome, Diverse Preclinical Models
Jason D. Roh, Joseph A. Hill, Abhilasha Singh, et al.
Circulation Research (2022) Vol. 130, Iss. 12, pp. 1906-1925
Open Access | Times Cited: 99
Heart failure with preserved ejection fraction: everything the clinician needs to know
Patricia Campbell, Frans H. Rutten, Matthew M.Y. Lee, et al.
The Lancet (2024) Vol. 403, Iss. 10431, pp. 1083-1092
Closed Access | Times Cited: 53
Of mice and men: models and mechanisms of diabetic cardiomyopathy
Christian Riehle, Johann Bauersachs
Basic Research in Cardiology (2018) Vol. 114, Iss. 1
Open Access | Times Cited: 155
Role of Leptin in Cardiovascular Diseases
Mareike S. Poetsch, Anna Strano, Kaomei Guan
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 136
Towards standardization of echocardiography for the evaluation of left ventricular function in adult rodents: a position paper of the ESC Working Group on Myocardial Function
Serena Zacchigna, Alessia Paldino, Inês Falcão‐Pires, et al.
Cardiovascular Research (2020) Vol. 117, Iss. 1, pp. 43-59
Open Access | Times Cited: 128
Key inflammatory mechanisms underlying heart failure
Christian Riehle, Johann Bauersachs
Herz (2019) Vol. 44, Iss. 2, pp. 96-106
Open Access | Times Cited: 101
HDAC inhibition improves cardiopulmonary function in a feline model of diastolic dysfunction
Markus Wallner, Deborah Eaton, Remus M. Berretta, et al.
Science Translational Medicine (2020) Vol. 12, Iss. 525
Open Access | Times Cited: 94
Inflammatory and Molecular Pathways in Heart Failure—Ischemia, HFpEF and Transthyretin Cardiac Amyloidosis
Diana Michels da Silva, Harald F. Langer, Tobias Graf
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 9, pp. 2322-2322
Open Access | Times Cited: 84
Inhibition of aquaporin-1 prevents myocardial remodeling by blocking the transmembrane transport of hydrogen peroxide
Virginie Montiel, Ramona Bella, Lauriane Y. M. Michel, et al.
Science Translational Medicine (2020) Vol. 12, Iss. 564
Open Access | Times Cited: 72
Metabolic Syndrome Mediates ROS-miR-193b-NFYA–Dependent Downregulation of Soluble Guanylate Cyclase and Contributes to Exercise-Induced Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction
Taijyu Satoh, Longfei Wang, Cristina Espinosa‐Díez, et al.
Circulation (2021) Vol. 144, Iss. 8, pp. 615-637
Open Access | Times Cited: 65
Small non-coding RNA therapeutics for cardiovascular disease
Ajay M. Shah, Mauro Giacca
European Heart Journal (2022) Vol. 43, Iss. 43, pp. 4548-4561
Open Access | Times Cited: 54
Adipokines and Cardiometabolic Heart Failure with Preserved Ejection Fraction: A State-of-the-Art Review
Nikolaos Theodorakis, Magdalini Kreouzi, Christos Hitas, et al.
Diagnostics (2024) Vol. 14, Iss. 23, pp. 2677-2677
Open Access | Times Cited: 11
Cardiac dysfunction in cancer patients: beyond direct cardiomyocyte damage of anticancer drugs: novel cardio-oncology insights from the joint 2019 meeting of the ESC Working Groups of Myocardial Function and Cellular Biology of the Heart
Carlo G. Tocchetti, Pietro Ameri, Rudolf A. de Boer, et al.
Cardiovascular Research (2020) Vol. 116, Iss. 11, pp. 1820-1834
Open Access | Times Cited: 69
HIV and Cardiovascular Disease: Update on Clinical Events, Special Populations, and Novel Biomarkers
Kaku So‐Armah, Matthew S. Freiberg
Current HIV/AIDS Reports (2018) Vol. 15, Iss. 3, pp. 233-244
Open Access | Times Cited: 60
Protease-activated receptor 2 deficiency mediates cardiac fibrosis and diastolic dysfunction
Julian Friebel, Alice Weithäuser, Marco Witkowski, et al.
European Heart Journal (2019) Vol. 40, Iss. 40, pp. 3318-3332
Closed Access | Times Cited: 54
Low-intensity pulsed ultrasound ameliorates cardiac diastolic dysfunction in mice: a possible novel therapy for heart failure with preserved left ventricular ejection fraction
Yuto Monma, Tomohiko Shindo, Kumiko Eguchi, et al.
Cardiovascular Research (2020) Vol. 117, Iss. 5, pp. 1325-1338
Closed Access | Times Cited: 47
2020 Clinical practice guidelines for Hypertrophic cardiomyopathy
С. А. Габрусенко, A. Ya. Gudkova, Н. А. Козиолова, et al.
Russian Journal of Cardiology (2021) Vol. 26, Iss. 5, pp. 4541-4541
Open Access | Times Cited: 40
Page 1 - Next Page

Scroll to top